HYPERTENSION
Scope & Guideline
Innovating treatment strategies for better outcomes.
Introduction
Aims and Scopes
- Clinical Research in Hypertension:
The journal features original research articles focusing on clinical trials, observational studies, and meta-analyses that explore the efficacy of various antihypertensive therapies, risk factors, and patient outcomes. - Mechanistic Insights into Hypertension Pathophysiology:
Numerous articles delve into the biological and molecular mechanisms underlying hypertension, including studies on the renin-angiotensin-aldosterone system, sympathetic nervous system activity, and inflammatory pathways. - Hypertension in Special Populations:
Research addressing hypertension in specific populations, such as pregnant women, children, and ethnic minorities, provides insights into the unique challenges and treatment responses in these groups. - Innovative Diagnostic and Monitoring Techniques:
The journal publishes studies on novel diagnostic tools and techniques, including home blood pressure monitoring, ambulatory blood pressure assessments, and the use of wearable technology for continuous monitoring. - Public Health and Epidemiological Studies:
A significant focus is placed on public health implications of hypertension, including epidemiological studies that track trends, prevalence, and the impact of social determinants on hypertension management. - Interdisciplinary Approaches to Hypertension Management:
The journal encourages interdisciplinary research that integrates perspectives from cardiology, nephrology, endocrinology, and public health to provide comprehensive hypertension management strategies.
Trending and Emerging
- Personalized Medicine and Genomics in Hypertension:
An increasing number of studies are focusing on genetic predispositions to hypertension, aiming to tailor treatment strategies based on individual genetic profiles and responses to therapy. - Impact of Gut Microbiota on Hypertension:
Emerging research highlights the role of gut microbiota and their metabolites in influencing blood pressure regulation, suggesting new therapeutic avenues involving dietary modifications and probiotics. - Digital Health and Telemedicine:
The integration of digital health technologies for remote monitoring and management of hypertension is gaining traction, with numerous studies exploring the efficacy and patient outcomes of telehealth interventions. - Inflammation and Immune Response in Hypertension:
There is a growing body of literature examining the inflammatory components and immune responses associated with hypertension, linking chronic inflammation to cardiovascular risk. - Hypertension and Cognitive Function:
Research is increasingly focusing on the relationship between hypertension and cognitive decline, exploring how blood pressure management may impact neurocognitive outcomes. - Social Determinants of Health in Hypertension Management:
Public health research is evolving to address the influence of social determinants on hypertension prevalence and control, emphasizing the need for community-based interventions.
Declining or Waning
- Traditional Pharmacological Approaches:
Research on conventional antihypertensive medications is becoming less frequent, as there is a growing emphasis on novel therapies, lifestyle interventions, and personalized medicine approaches. - Salt Restriction Studies:
Although salt intake remains a significant risk factor for hypertension, studies specifically focusing on dietary sodium restriction are appearing less frequently, potentially due to a shift towards more comprehensive dietary patterns and overall lifestyle modifications. - Longitudinal Studies of Hypertension Progression:
There seems to be a decrease in publications focusing solely on long-term observational studies tracking hypertension progression, as newer studies emphasize more immediate therapeutic interventions and outcomes. - Basic Science Studies Without Clinical Application:
The journal appears to be moving away from basic science studies that do not have clear clinical applications, favoring research that directly informs patient care and management strategies.
Similar Journals
BLOOD PRESSURE MONITORING
Transforming blood pressure management practices.BLOOD PRESSURE MONITORING is a distinguished academic journal published by Lippincott Williams & Wilkins, dedicated to advancing the study of blood pressure measurement and management across various medical disciplines. With an ISSN of 1359-5237 and an E-ISSN of 1473-5725, this journal has consistently contributed to the field since its inception in 1996, continuing to provide invaluable insights through 2024. Notably, the journal ranks in the Q2 quartile for Advanced and Specialized Nursing and Assessment and Diagnosis, illustrating its influence in these areas, while also making significant contributions to Cardiology, Internal Medicine, and broader Medical research. Although it does not currently offer open access, BLOOD PRESSURE MONITORING remains essential reading for researchers, healthcare professionals, and students, eager to stay at the forefront of blood pressure research and its critical implications in clinical practice. The journal's commitment to quality and rigor makes it a vital resource for anyone involved in the continuously evolving fields of cardiovascular health and patient monitoring.
KIDNEY & BLOOD PRESSURE RESEARCH
Connecting Researchers to Combat Kidney and Blood Pressure Challenges.Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.
Current Hypertension Reviews
Pioneering Knowledge in Cardiovascular DisordersCurrent Hypertension Reviews, published by Bentham Science Publishers Ltd, stands as a leading journal in the field of internal medicine, particularly focusing on hypertension and related cardiovascular disorders. With an impressive impact factor and ranked #59 out of 167 in the Scopus medicine category, this journal highlights key insights and contemporary research trends from its inception in 2006 to 2024. Its commitment to making high-quality research accessible to the medical community, despite lacking an Open Access option, ensures that it continues to contribute significantly to the scientific discourse surrounding hypertension management and innovative treatments. Researchers, clinicians, and students alike will find valuable resources within its pages, as Current Hypertension Reviews plays a critical role in advancing the understanding and treatment of hypertension, ultimately supporting better health outcomes globally.
Arterial Hypertension
Innovating treatment strategies for better health outcomes.Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.
Clinical Hypertension
Bridging knowledge and practice in hypertension.Clinical Hypertension is a premier journal dedicated to advancing the field of hypertension and cardiovascular health, published by SpringerNature. Since its transition to an Open Access model in 2014, the journal has opened doors for researchers globally to share their findings without barriers, aiming to foster collaboration and innovation in this vital area of medicine. With a current impact factor that positions it in the Q2 quartile for both Cardiology and Cardiovascular Medicine and Internal Medicine, Clinical Hypertension is recognized for its scholarly contributions, reflected in its Scopus rankings (Rank #100/387 in Cardiology and Rank #52/167 in Internal Medicine), which place it in the top percentiles of these competitive fields. Covering a diverse range of topics within hypertension research, it serves as an essential resource for clinicians, researchers, and students alike, promising to keep its audience informed of the latest developments and breakthroughs from its inception in 2017 through to 2024.
Asian Biomedicine
Bridging Knowledge Gaps in Biomedical SciencesAsian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.
JOURNAL OF HYPERTENSION
Unlocking the complexities of hypertension for better patient outcomes.JOURNAL OF HYPERTENSION, published by Lippincott Williams & Wilkins, stands at the forefront of cardiovascular research, serving as a premier platform for the dissemination of knowledge in hypertension and related cardiovascular conditions. With an impressive impact factor, this esteemed journal is recognized in Q1 quartile across multiple categories, including Cardiology, Internal Medicine, and Physiology as of 2023, firmly establishing its significance within the academic community. The journal has been a reliable source of cutting-edge research since its inception in 1983, with continued publication through 2024. Researchers can expect a rigorous peer-review process and a diverse array of articles that include original research, reviews, and clinical studies aimed at enhancing the understanding and management of hypertension. Although it is not an open-access journal, the JOURNAL OF HYPERTENSION remains invaluable to clinicians, researchers, and students dedicated to advancing the field of cardiovascular health.
CLINICAL SCIENCE
Empowering Researchers to Shape Medical FuturesCLINICAL SCIENCE, published by PORTLAND PRESS LTD, is a prestigious journal with an established history that dates back to 1946. Renowned for its rigorous peer-reviewed articles, the journal is dedicated to advancing knowledge in the field of medicine, particularly in the nuances of clinical science and translational research. With an impressive Q1 ranking in the **Medicine (miscellaneous)** category and a Scopus rank of #32 out of 636 in general medicine, it is firmly positioned in the top 5% percentile of its field, making it an essential resource for researchers, practitioners, and students aiming to stay at the forefront of the discipline. Although the journal operates on a traditional subscription model, its influence and accessibility ensure that critical findings and innovative methodologies reach a wide audience, fostering collaboration and progress within the global medical community. The journal seeks to publish groundbreaking studies, critical reviews, and insights that can translate into improved clinical practices, thus reinforcing its mission to enhance patient care and medical knowledge.
Respiratory Investigation
Transforming insights into impactful respiratory solutions.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
Integrated Blood Pressure Control
Fostering Collaboration in Cardiovascular MedicineIntegrated Blood Pressure Control is a distinguished Open Access journal published by DOVE MEDICAL PRESS LTD in New Zealand, dedicated to advancing the field of cardiology and cardiovascular medicine as well as internal medicine. With its established timeline from 2009 to 2024, this journal has earned a commendable Q2 ranking in both its categories for 2023, reflecting its significant contribution to clinical research and practice. With an ISSN of 1178-7104, it provides a platform for high-quality, peer-reviewed articles that address the complexities of blood pressure management, aiming to improve patient outcomes and foster discussions among healthcare professionals. The journal's open-access model, implemented since 2008, ensures that research findings are readily available to all, promoting greater accessibility and dissemination of knowledge in this critical area of health. Researchers, professionals, and students alike are encouraged to engage with the latest findings and innovative practices published within this journal, which plays an essential role in shaping the future of blood pressure control and related medical fields.